PRA Health Sciences, Inc.
PRAH
PRAH was delisted on the 30th of June, 2021.
278 hedge funds and large institutions have $5.29B invested in PRA Health Sciences, Inc. in 2018 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 89 increasing their positions, 108 reducing their positions, and 36 closing their positions.
11% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 36
1% less call options, than puts
Call options by funds: $2.34M | Put options by funds: $2.37M
1% less funds holding
Funds holding: 282 → 278 (-4)
7% less capital invested
Capital invested by funds: $5.69B → $5.29B (-$394M)
18% less repeat investments, than reductions
Existing positions increased: 89 | Existing positions reduced: 108
50% less funds holding in top 10
Funds holding in top 10: 10 → 5 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$81.8M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$65.4M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
+$58.4M |
| 4 |
Bank of New York Mellon
New York
|
+$54.4M |
| 5 |
TPI
Tesco Pension Investment
London,
United Kingdom
|
+$28M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$49.7M |
| 2 |
MWNA
Marshall Wace North America
New York
|
-$24M |
| 3 |
Russell Investments Group
London,
United Kingdom
|
-$16.5M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$14.7M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$13.2M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
301
Jane Street
New York
| – | -$304K | -3,342 | Closed |
|
302
Wolverine Trading
Chicago,
Illinois
| – | -$287K | -3,155 | Closed |
|
|
SEC
303
Seven Eight Capital
New York
| – | -$264K | -2,900 | Closed |
|
|
ECM
304
ETrade Capital Management
Arlington,
Virginia
| – | -$246K | -2,702 | Closed |
|
|
PM
305
Parametrica Management
Wanchai,
Hong Kong
| – | -$232K | -2,547 | Closed |
|
|
SRAM
306
Stone Ridge Asset Management
New York
| – | -$211K | -2,318 | Closed |
|
|
IB
307
Intrust Bank
Wichita,
Kansas
| – | -$204K | -2,237 | Closed |
|
308
Simplex Trading
Chicago,
Illinois
| – | -$72K | -810 | Closed |
|
|
DSC
309
Duncker Streett & Co
St. Louis,
Missouri
| – | -$55K | -600 | Closed |
|
|
DCM
310
Delpha Capital Management
New York
| – | -$22K | -246 | Closed |
|
|
TFA
311
Toth Financial Advisory
Leesburg,
Virginia
| – | -$15K | -160 | Closed |
|
312
Lazard Asset Management
New York
| – | -$10K | -110 | Closed |
|
|
CWM
313
Catamount Wealth Management
Westport,
Connecticut
| – | -$6K | -65 | Closed |
|
PRAH Hedge Fund Activity: Q1 2018 in Review
278 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in PRA Health Sciences, Inc. (PRAH) for Q1 2018, worth a combined $5.29B — down 6.9% from $5.69B a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new PRAH positions and 36 closed out — a net gain of 4 holders — while 89 added to existing stakes and 108 trimmed.
The largest buyer was Capital Research Global Investors, adding an estimated $81.8M. The largest seller was Millennium Management, cutting an estimated $49.7M.
- 278 institutional investors held PRA Health Sciences, Inc. (PRAH) as of Q1 2018, down from 282 in Q4 2017.
- Funds reported $5.29B of PRA Health Sciences, Inc. stock for Q1 2018, down 6.9% quarter-over-quarter.
- 40 funds opened new PRA Health Sciences, Inc. positions in Q1 2018 and 36 closed out, a net change of +4 holders.
- The largest PRA Health Sciences, Inc. buyer in Q1 2018 was Capital Research Global Investors, an estimated $81.8M added.
- The largest PRA Health Sciences, Inc. seller in Q1 2018 was Millennium Management, an estimated $49.7M sold.
Based on aggregated 13F filings for Q1 2018.